Latest News in the pharma Industry

Top Stories

New HIV-1 drug approved

New HIV-1 drug approved

25 Mar 2013

EU to get new drug for treating HIV-1 infection.

Read more 
US authorities accept patent for TECFIDERA

US authorities accept patent for TECFIDERA

20 Mar 2013

Officials in the US have given their approval to the patent.

Read more 
Expert reveals fall of clinical trials in Europe

Expert reveals fall of clinical trials in Europe

20 Mar 2013

Meir Pugatch explained that Europe has a low level of clinical trials activity.

Read more 
Pharma companies discuss role of IT in the industry

Pharma companies discuss role of IT in the industry

19 Mar 2013

IT is helping scientists to spend more money on actual lab work.

Read more 
AstraZeneca to invest in boosting research and development prowess

AstraZeneca to invest in boosting research and development prowess

19 Mar 2013

AstraZeneca will invest in several of its existing research and development centres around the world.

Read more 
Breast cancer drug given regulatory green light

Breast cancer drug given regulatory green light

16 Mar 2013

A new drug to treat HER2-positive breast cancer has received regulatory approval in the UK.

Read more 
New drug formulations to be cheaper thanks to research efficiency

New drug formulations to be cheaper thanks to research efficiency

15 Mar 2013

The pharmaceutical industry could benefit by developing new drug formulations that are cheaper than existing remedies.

Read more 
UK to change patent laws to attract clinical trials

UK to change patent laws to attract clinical trials

15 Mar 2013

The UK government intends to take steps to attract drug research and development projects back to the UK.

Read more 
Apposition III clinical trials show low mortality rates

Apposition III clinical trials show low mortality rates

11 Mar 2013

The Stentys Self-Apposing Stent clinical trials show low death rates in patients following severe heart attack.

Read more 
Drug formulation developer Dyax announces board changes

Drug formulation developer Dyax announces board changes

11 Mar 2013

The executive vice president chief operating officer of the company, which specialises in drug formulations for unmet medical needs, is leaving for other opportunities.

Read more 
Rheumatoid arthritis clinical trial to continue

Rheumatoid arthritis clinical trial to continue

8 Mar 2013

Drug formulation PRTX-100 passed a scheduled interim data safety monitoring committee meeting.

Read more 
OncoMed begins Phase 1 clinical trial of stem cell drug

OncoMed begins Phase 1 clinical trial of stem cell drug

8 Mar 2013

OMP-52M51 is a therapeutic that targets cancer stem cells.

Read more